Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Trends in mortality due to lymphoma and pulmonary embolism in the United States, 1999–2020: A CDC wonder database population analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

FDFnu DeekshaAMAli Sanjari MoghaddamAZAbdullah Zia

Discussion

Loading...

Member takes

Overview

Population analysis reveals rising mortality from lymphoma and pulmonary embolism, highlighting cancer-associated thrombosis and demographic disparities.

Key Points

  • Mortality rates from lymphoma and pulmonary embolism have begun to rise after a period of decline.
  • Joinpoint regression indicated an annual percent change of +10.78% from 2017 to 2020.
  • The increased mortality was particularly noted among older adults and various racial groups, emphasizing disparities.
  • These findings underscore the need for better screening and preventive care in lymphoma patients.

Cite This Study

Deeksha et al. (2025) studied this question.

synapsesocial.com/papers/69362f3a4fa91c937236d433https://doi.org/10.1182/blood-2025-8058
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mortality from pulmonary embolism among patients with lung and bronchus malignancies: National trends and forecasting from CDC WONDER (1999–2030).2026
  2. 2Trends and Disparities in Pulmonary Embolism Mortality in the United States, 1999– 20232025
  3. 3Trends in mortality from deep vein thrombosis and pulmonary embolism as multiple causes of death in u.S. adults aged ≥65 years (1999–2023): A CDC wonder analysis2025 · 2 citations
  4. 4Trends in thromboembolism-related mortality among patients with hematologic malignancies in the u.S., 1999–2023: A CDC wonder analysis2025 · 1 citations
  5. 5Temporal trends in cancer-associated venous thromboembolism mortality: A nationwide analysis (1999–2020)2025